← Eichor
Study identifier: NCT06257407 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Perioperative Hemostasis Management in Liver Transplantation

Condition: Liver Transplant; Complications  ·  Sponsor: Société Française d'Anesthésie et de Réanimation

PhaseN/A
Planned participants1200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Liver transplantation (LT) is a surgery with risk of bleeding. Several risk factors have been identified: complex dissection, portal hypertension, history of ascites fluid infections, history of surgical procedures, pre-existing complex hemostatic disorders and those acquired during the procedure. Diffuse bleeding can occur at any time during the 3 phases of surgery: dissection, anhepatic and neohepatic. However, intraoperative bleeding and transfusion requirements remain difficult to predict. Current predictive models are based in particular on preoperative characteristics and do not take into account the course and different phases of the operation. The need for transfusions has largely decreased over the last 20 years, and currently around 20-25% of patients are transfused (transfusion of at least 1 blood product during LT). However, massive transfusion is necessary in 10% of LT. The European Society of Anaesthesiology (ESA) has issued recommendations on the management of severe bleeding during surgery. However, these recommendations are not specific to LT. Moreover, transfusion strategies vary widely from one center to another. The implementation of protocols within teams dedicated to LT has led to a reduction in bleeding and transfusion, with or without the use of viscoelastic testing. Intraoperative bleeding and transfusion requirements, as well as postoperative thromboembolic complications, remain difficult to predict. Predictive models of bleeding risk have been dev…

This description comes directly from the study's public registry record.

Talk to the study team

Emmanuel WEISS, MD  ·  +33 1 40 87 58 81  ·  emmanuel.weiss@aphp.fr

Stéphanie ROULLET, MD  ·  +33 1 45 59 32 19  ·  stephanie.roullet@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (16)

Chru MinjozBesançon, FranceRecruiting
CHU EstaingClermont, FranceNot Yet Recruiting
Hôpital BeaujonClichy, FranceNot Yet Recruiting
CHU Grenoble AlpesGrenoble, FranceNot Yet Recruiting
CHU Claude HuriezLille, FranceRecruiting
Hôpital de la Croix-RousseLyon, FranceRecruiting
CHU La TimoneMarseille, FranceNot Yet Recruiting
Hôpital St EloiMontpellier, FranceNot Yet Recruiting
Hôpital De L'Archet 2Nice, FranceNot Yet Recruiting
CHU Pitié-SalpêtrièreParis, FranceNot Yet Recruiting
CHU Haut LevêquePessac, FranceNot Yet Recruiting
CHU PontchaillouRennes, FranceNot Yet Recruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06257407